Zobrazeno 1 - 10
of 131
pro vyhledávání: '"Bilgin O"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Georgios Eleftheriadis, Marcel G. Naik, Bilgin Osmanodja, Lutz Liefeldt, Fabian Halleck, Mira Choi, Eva Schrezenmeier, Bianca Zukunft, Andrea Tura, Klemens Budde
Publikováno v:
Transplant International, Vol 37 (2024)
Post-transplantation diabetes mellitus (PTDM) and prediabetes are associated with increased cardiovascular morbidity and mortality in kidney transplant recipients (KTR), when diagnosed by an oral glucose tolerance test (oGTT). Hemoglobin A1c (HbA1c)
Externí odkaz:
https://doaj.org/article/7aa8b404312040629d8fc3aa05612f0a
Autor:
Peter Dabrock, David Samhammer, Zeineb Sassi, Sascha Eickmann, Sebastian Möller, Roland Roller, Bilgin Osmanodja, Aljoscha Burchardt, Klemens Budde, Anne Herrmann
Publikováno v:
BMJ Open, Vol 14, Iss 10 (2024)
Introduction As healthcare is shifting from a paternalistic to a patient-centred approach, medical decision making becomes more collaborative involving patients, their support persons (SPs) and physicians. Implementing shared decision-making (SDM) in
Externí odkaz:
https://doaj.org/article/54cc72177b6a418cb6204f7533c731ad
Publikováno v:
Cereal Research Communications, 2010 Jun 01. 38(2), 233-242.
Externí odkaz:
https://www.jstor.org/stable/23790305
Autor:
Aylin Akifova, Klemens Budde, Michael Oellerich, Julia Beck, Kirsten Bornemann-Kolatzki, Ekkehard Schütz, Bilgin Osmanodja
Publikováno v:
Transplant International, Vol 37 (2024)
Antibody-mediated rejection (AMR) is a major cause of graft failure limiting long-term graft survival after kidney transplantation. Current diagnostic strategy to detect AMR is suboptimal and requires further improvement. Previously suggested treatme
Externí odkaz:
https://doaj.org/article/c5f5cdb1e10e4bbd8969ac1783f2fef8
Donor-Derived Cell-Free DNA as a Companion Biomarker for AMR Treatment With Daratumumab: Case Series
Autor:
Bilgin Osmanodja, Aylin Akifova, Klemens Budde, Michael Oellerich, Julia Beck, Kirsten Bornemann-Kolatzki, Ekkehard Schütz, Joachim Velden, Claudia Lehmann, Bastian Malte Krüger, Anette Bachmann, Jan Kowald
Publikováno v:
Transplant International, Vol 37 (2024)
Antibody-mediated rejection (AMR) is among the most frequent causes for graft loss after kidney transplantation. While there are no approved therapies, several case reports with daratumumab and the very recent phase 2 trial of felzartamab in AMR have
Externí odkaz:
https://doaj.org/article/eb3adfe1fba0494988371dddb823ccfe
This study was conducted to determine changes for some quality characters in M2, M3 and M4 mutated populations of three bread wheat genotypes irradiated by different gamma rays. The results showed that the genotypes significantly and variably differe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10334::b885908a5b9ed8b814ccea41da22e2a1
https://hdl.handle.net/20.500.11776/10184
https://hdl.handle.net/20.500.11776/10184
Publikováno v:
Brain Sciences, Vol 14, Iss 10, p 1019 (2024)
In the original publication [...]
Externí odkaz:
https://doaj.org/article/ee99547696db475ab67d8a4a8b2d0867
Autor:
Bilgin Osmanodja, Zeineb Sassi, Sascha Eickmann, Carla Maria Hansen, Roland Roller, Aljoscha Burchardt, David Samhammer, Peter Dabrock, Sebastian Möller, Klemens Budde, Anne Herrmann
Publikováno v:
JMIR Research Protocols, Vol 13, p e54857 (2024)
BackgroundPatients after kidney transplantation eventually face the risk of graft loss with the concomitant need for dialysis or retransplantation. Choosing the right kidney replacement therapy after graft loss is an important preference-sensitive de
Externí odkaz:
https://doaj.org/article/acb5486d8bc2470cbdcf315e4482fef4